GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide
Empower Pharmacy was already challenging the Tirzepatide patent claiming its an obvious extension of prior dual agonist disclosures
IV nutrient therapy isnt a cure for fibromyalgia, but for many, it provides a noticeable improvement in how they feel day to day
Chronic conditions impacting absorption include atrophic gastritis or pernicious anaemia, where there is a lack of intrinsic factor, a protein essential for the uptake of B12 in the digestive tract
Lorsqu'il neutralise les radicaux libres, le GSH cde un lectron et se transforme en glutathion oxyd (GSSG)
Interestingly, in the context of HD, Hefny et al